Original Article
In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017–2019
James A. Karlowskya, Krystyna M. Kazmierczakb,
, Maria Lavínea Novis de Figueiredo Valentec, Elkin Lemos Luengasd, Monique Baudrite, Alvaro Quintanaf, Paurus Iranig, Gregory G. Stoneh, Daniel F. Sahmb
Corresponding author
a University of Manitoba, Max Rady College of Medicine, Department of Medical Microbiology and Infectious Diseases, Winnipeg, Canada
b IHMA, Schaumburg, IL, USA
c Pfizer Brazil, São Paulo, SP, Brazil
d Pfizer Colombia, Bogota, Colombia
e Pfizer Central America and Caribbean, Cartago, Costa Rica
f Pfizer Inc., New York, NY, USA
g Pfizer UK ltd, Walton Oaks, Tadworth, Surrey, UK
h Pfizer Inc., Groton, CT, USA
Read
1744
Timeswas read the article
669
Total PDF
904
Total HTML
171
Total EPUB
| Year/Month | Html | Epub | Total | |
|---|---|---|---|---|
| 2023 February | 0 | 0 | 0 | 0 |
| 2023 January | 28 | 31 | 1 | 60 |
| 2022 December | 61 | 40 | 9 | 110 |
| 2022 November | 69 | 34 | 10 | 113 |
| 2022 October | 57 | 28 | 12 | 97 |
| 2022 September | 44 | 70 | 17 | 131 |
| 2022 August | 35 | 44 | 13 | 92 |
| 2022 July | 61 | 49 | 9 | 119 |
| 2022 June | 67 | 56 | 18 | 141 |
| 2022 May | 50 | 26 | 4 | 80 |
| 2022 April | 77 | 41 | 11 | 129 |
| 2022 March | 87 | 59 | 16 | 162 |
| 2022 February | 105 | 50 | 13 | 168 |
| 2022 January | 73 | 49 | 14 | 136 |
| 2021 December | 67 | 62 | 15 | 144 |
| 2021 November | 23 | 30 | 9 | 62 |
Show all
